indirubin-3'-monoxime has been researched along with Granulocytic Leukemia in 2 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, JH | 1 |
| Lee, JE | 1 |
| Cho, KM | 1 |
| Park, SH | 1 |
| Kim, HJ | 1 |
| Kim, YC | 1 |
| Kim, TS | 1 |
| Zhen, Y | 1 |
| Sørensen, V | 1 |
| Jin, Y | 1 |
| Suo, Z | 1 |
| Wiedłocha, A | 1 |
2 other studies available for indirubin-3'-monoxime and Granulocytic Leukemia
| Article | Year |
|---|---|
5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities.
Topics: Antineoplastic Agents; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistanc | 2016 |
Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Topics: Animals; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinase 2; Endocytosis; ErbB Receptors; Fib | 2007 |